Tags: Drug.

Pascolizumab is a humanized monoclonal antibody for the treatment of asthma. A Phase II clinical trial in patients with symptomatic glucocorticoid naive asthma has been conducted in 2001/2002.

ATC prefix
none
CAS number
331243-22-2
FDA UNII code
N1IOA09R6A

Loading...

This page contains content from the copyrighted Wikipedia article "Pascolizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.